Skip to main content

To Be or Not to Be: Entrepreneurship and Enterprise Creation as a Way to Innovate in Life Sciences

  • Chapter
  • First Online:
Career Options in the Pharmaceutical and Biomedical Industry

Abstract

New market opportunities in the life sciences will emerge in the next few years, thanks to scientific advancements and the need for entrepreneurs who can address these opportunities is following such a trend. The role of companies, in particular of innovative start-ups in contributing to the development and economic growth of society and in the development of healthcare-related solutions, has been extensively studied. Unfortunately it has been clear since at least a decade that there is a profound mismatch between the traditional role of doctoral education in preparing young researchers for an academic career. Particularly in life sciences the existence of pure scientific results, however excellent they may be, does not automatically entail their transformation into innovative activities. This is the reason why the role of the researcher within the entrepreneurial process of a high-tech start-up—particularly in the field of biotechnology—is fundamental, especially in the initial stages. Examples of focused training and supporting solutions are existing but still not standardised. On the other hand, the need to maximise the impact of scientific research on society requires curricula, particularly for STEM (Science, Technology, Engineering and Mathematics) students, which will explicitly include entrepreneurial and innovation management components as transformative tools to maximise their contribution to society.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 59.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    The value proposition will include, at least, research of excellence description, its protection (the patent), the definition of a strategy and the formalization of these in documents to be shared (business plan, pitch and business model) will allow to introduce oneself to initially close and informal investors (the three ‘3F’, family friends and fools ‘and business angels’) and then to more and more professional actors (‘seeds and venture capitalists’) in order to attract economic resources which, with additional public funding.

References

Download references

Acknowledgements

This article has been conceptualised by EuroScience’s Science Policy Workgroup on Innovation and Entrepreneurship. The authors wish to thank Teresa Fernandez, Nandakumar Krishnaswamy, Olayinka Osuolale and Violeta Greciuhin for their critical revision of the initial manuscript.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cahill, B., Conicella, F., Galligan, E., Györffi, M. (2023). To Be or Not to Be: Entrepreneurship and Enterprise Creation as a Way to Innovate in Life Sciences. In: Thomas, J.R., Saso, L., van Schravendijk, C. (eds) Career Options in the Pharmaceutical and Biomedical Industry . Springer, Cham. https://doi.org/10.1007/978-3-031-14911-5_15

Download citation

Publish with us

Policies and ethics